Sign up to save your podcasts
Or
Share ACC CardiaCast: Risk-Benefit Analysis and Dosing
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ACC CardiaCast: Risk-Benefit Analysis and Dosing
This podcast discusses the risks and benefits of starting new diabetes therapies on a patient with type 2 diabetes. As the incidence of type 2 diabetes mellitus rises in the United States, understanding the cardioprotective effects of new drug classes will prepare you to better treat your patients.
View all episodes
By American College of Cardiology
4.4
3737 ratings
This podcast discusses the risks and benefits of starting new diabetes therapies on a patient with type 2 diabetes. As the incidence of type 2 diabetes mellitus rises in the United States, understanding the cardioprotective effects of new drug classes will prepare you to better treat your patients.
More shows like ACC CardiaCast
View all
JAMA Editors' Summary
137 Listeners
NEJM This Week
320 Listeners
JAMA Clinical Reviews
497 Listeners
JACC This Week
169 Listeners
This Week in Cardiology
885 Listeners
Mayo Clinic Talks
290 Listeners
The Curbsiders Internal Medicine Podcast
3,343 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
140 Listeners
Core IM | Internal Medicine Podcast
1,156 Listeners
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
61 Listeners
Annals On Call Podcast
195 Listeners
JAMA Medical News
90 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
364 Listeners
Run the List
253 Listeners
Cardionerds: A Cardiology Podcast
430 Listeners